Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation

DSpace/Manakin Repository

Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation

Citable link to this page

 

 
Title: Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation
Author: Min, Chul Hee; Paganetti, Harald; Winey, Brian A; Adams, Judith; MacDonald, Shannon M; Tarbell, Nancy J; Yock, Torunn I

Note: Order does not necessarily reflect citation order of authors.

Citation: Min, Chul Hee, Harald Paganetti, Brian A Winey, Judith Adams, Shannon M MacDonald, Nancy J Tarbell, and Torunn I Yock. 2014. “Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation.” Radiation Oncology (London, England) 9 (1): 220. doi:10.1186/s13014-014-0220-8. http://dx.doi.org/10.1186/s13014-014-0220-8.
Full Text & Related Files:
Abstract: Background: To precisely calculate skin dose and thus to evaluate the relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with proton beams. Methods: The dosimetry and alopecia outcomes of 12 children with medulloblastoma (ages 4-15 years) comprise the study cohort. Permanent alopecia was assessed and graded after completion of the entire therapy. Skin threshold doses of permanent alopecia were calculated based on the skin dose from the craniospinal irradiation (CSI) plan using the concept of generalized equivalent uniform dose (gEUD) and accounting for chemotherapy intensity. Monte Carlo simulations were employed to accurately assess uncertainties due to beam range prediction and secondary particles. Results: Increasing the dose of the CSI field or the dose given by the boost field to the posterior fossa increased total skin dose delivered in that region. It was found that permanent alopecia could be correlated with CSI dose with a threshold of about 21 Gy (relative biological effectiveness, RBE) with high dose chemotherapy and 30 Gy (RBE) with conventional chemotherapy. Conclusions: Our results based on 12 patients provide a relationship between the skin dose and permanent alopecia for pediatric medulloblastoma patients treated with protons. The alopecia risk as assessed with gEUD could be predicted based on the treatment plan information.
Published Version: doi:10.1186/s13014-014-0220-8
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251676/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:13581132
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters